Opinion
The war over Ozempic isn’t helping overweight Australians
The drug regulators’ decision to ban compounded weight loss drugs won’t help those suffering health complications from obesity.
Nick CoatsworthFormer deputy chief health officerThe drug regulators’ decision to take the low road and ban compounded weight loss drugs won’t help those suffering health complications from obesity.
There is a war over Ozempic at the moment. The players in this war are many and share one thing in common: their actions aren’t helping overweight Australians.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Health & education
Fetching latest articles